W-SCOPE Corporation

6619.T
Electrical Equipment & Parts
2026/09/28 18:47 Updated
Market Cap: $57.1M (¥9.0B)
Stock Price: $0.95 (¥149)
Exchange Rate: 1 USD = ¥157.48

Notice of Differences between the Consolidated Earnings Forecast for the First Half of the Fiscal Year ending January 2027 and Actual Results

Due to delays in subsidies recovery for European EVs and slower shipments for solid-state separators, sales in the second quarter of the fiscal year ending January 2027 fell short of plan by 1,071 million yen to 1,928 million yen, operating income declined by 1,388 million yen to -1,388 million yen, ordinary income declined by 3,091 million yen to -3,091 million yen, and net income attributable to owners of the parent fell by 3,104 million yen to -3,104 million yen. The full-year forecast remains unchanged.

Importance:
Page Updated: September 10, 2026
IR Disclosure Date: September 10, 2026

Key Figures

  • Sales: 1,928 百万円(前回予想比 △1,071 百万円)
  • Operating profit: △1,388 百万円(前回予想比 △188 百万円)
  • Net income attributable to owners of the parent: △3,104 百万円(前回予想比 △204 百万円)

AI要約

Performance overview

For the first half, sales were 1,928 million yen, down about 1,071 million yen from the plan, as the recovery of subsidies in the European market for EVs and delayed shipments to ESS reduced sales in the Separator business. A drop in production utilization due to lower Separator sales lowered operating income to △1,388 million yen (down 188 million yen vs. plan). Ordinary income declined by 191 million yen to △3,091 million yen, and net income attributable to owners of the parent fell by 204 million yen to △3,104 million yen, with earnings per share of △51.62 yen.

Outlook and impact

The full-year consolidated earnings forecast remains unchanged. For the Separator business, domestic sales are expected to accelerate in the second half, and shipments are expected to exceed the plan as ESS-related sales recover. In the ion-exchange membrane business, existing orders are robust, and new semiconductor-related and wastewater treatment projects are scheduled to commence shipments in the second half or later, contributing to sales growth in the next fiscal year and beyond.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

W-SCOPE Corporation

Company overview · Stock price · Financial data · All IR

View company page →